UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Premier Fund Managers Ltd

Premier Fund Managers Ltd reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 100,000 shares of the healthcare conglomerate's stock after selling 10,000 shares during the period. UnitedHealth Group makes up approximately 2.1% of Premier Fund Managers Ltd's investment portfolio, making the stock its 18th biggest holding. Premier Fund Managers Ltd's holdings in UnitedHealth Group were worth $58,179,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Price T Rowe Associates Inc. MD raised its position in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate's stock worth $12,893,331,000 after buying an additional 94,641 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in UnitedHealth Group by 0.4% in the second quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate's stock valued at $4,094,247,000 after purchasing an additional 35,533 shares during the last quarter. International Assets Investment Management LLC raised its stake in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after buying an additional 5,290,025 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in UnitedHealth Group by 30.0% during the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate's stock worth $1,942,956,000 after acquiring an additional 880,183 shares during the period. Finally, Ameriprise Financial Inc. lifted its holdings in UnitedHealth Group by 0.6% in the second quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate's stock valued at $1,920,039,000 after acquiring an additional 21,149 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UNH traded up $18.27 on Wednesday, reaching $595.27. The company had a trading volume of 1,517,159 shares, compared to its average volume of 3,869,562. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $547.82 billion, a PE ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58. The stock has a 50-day moving average price of $582.31 and a 200-day moving average price of $551.25.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period last year, the firm posted $6.56 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.41%. UnitedHealth Group's dividend payout ratio (DPR) is presently 54.72%.

Analyst Ratings Changes

UNH has been the topic of several analyst reports. Barclays dropped their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an "overweight" rating on the stock in a research report on Tuesday, October 22nd. TD Cowen increased their price target on UnitedHealth Group from $601.00 to $609.00 and gave the stock a "buy" rating in a research report on Friday, October 18th. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an "overweight" rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Thursday, October 17th. Finally, StockNews.com cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Wednesday. Four research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.